UCB in Epilepsy and Rare Syndromes
For three decades, we’ve been committed to people living with epilepsy and their families, surrounding the patient and caregiver through every step of their care journey – from diagnosis to treatment to support in helping them navigate those moments in their lives that matter most. Because we must find solutions for seizures that won’t stop, not only to preserve those moments, but to protect the minds and the lives of those living with epilepsy and rare syndromes.
Driven by Patient Value
At our core, we have a profound responsibility to elevate the healthcare ecosystem. It is a responsibility that extends to the very heart of our purpose – patients, and their families. Thirty years ago, we ushered in a new era of epilepsy therapies largely due to our scientific breakthrough, introducing a completely unique and novel mechanism of action in the treatment of epilepsy and, we continued to redefine the SV2A class of medicines to treat seizures.
Commitment to People, Purpose and Science
We will continue to reimage how we care for patients, leveraging today s expertise for a better tomorrow. We are doing so, in many instances, on our own as we look at potential solutions for rapid seizure termination, our work in Developmental and Epileptic Encephalopathies (DEEs), and our pursuits in gene modification. But we understand that with the complexity of the ecosystem, there are instances where we will need to partner with purpose. Therefore, we are also pursuing external research collaborations to validate new potential therapeutic targets. With so much experience behind us and so much potential ahead, we are more invested than ever in profoundly improving the lives of those living with or caring for those with epilepsy or a rare epilepsy syndrome.

Breaking the Barriers
to Better Care
We are working to remove barriers to better, healthier living. And our work isn t only about delivering therapeutic solutions to those whose health will benefit from them. It extends to empowering people through support offerings, advocacy, access and affordability programs, education, acquisitions, community support and advances in technology. By actively and strategically seeking out collaborations with well placed partners, we are able to deliver on our mission to provide long term value to patients and their families as well as their larger care teams.

Responsibility to Advance
the Ecosystem of Care
We are proud of our legacy of successful advancements in the treatment of epilepsies, but there is still work to be done to ensure that a life managing seizures doesn’t become a life all about seizures. We are forward facing, looking ahead to cutting edge approaches to treatment. We are continually recommitting to further research, partnerships, and strategic acquisitions to benefit people living with epilepsy and its rare syndromes while always pursuing more precise science to address the specific unmet needs of people living with these conditions everywhere. We are leveraging today s expertise to bring a better tomorrow for those we serve.

Precise Medicine to Drive
Holistic Care
The science we pursue is always centered around the patient, providing personalized care that impacts a real, unmet need. Our work places a premium on holistic treatments that focus on overall quality of life. In DS and LGS we look to improve outcomes in seizure control, non seizure outcomes such as sleep, cognition and behavior, as well as survival outcomes. We have one million compounds per drug screening, over 500 protein targets reviewed through our AI/digital pathobiology framework, and more than 250 interventional studies with over 25,000 people enrolled.
Resources

VIP Sibling
We partnered with the Lennox-Gastaut Syndrome (LGS) Foundation and Dravet Syndrome(DS) Foundation to compile the Siblings Voices Survey to assess how children adapt to growing up with siblings living with a rare form of epilepsy and created our VIP Sibling Project that includes resources to support siblings, parents, and caregivers of people living with a rare epilepsy syndrome.

SUDEP
We worked with more than 20 organizations committed to this community such as American Epilepsy Society, Danny Did Foundation, and the Epilepsy Foundation, and Child Neurology Foundation (CNF), to support the creation a toolkit of resources to raise awareness of potential causes of SUDEP.

Digital Care Transformation
We continuously seek to innovate for the future creating our Digital Care Transformation incubator. Through this initiative, we support healthcare startups developing innovative solutions for epilepsy, such as NeuroHelp and Epihunter, using AI and wearable technology. We have also invested in detection and monitoring device companies like Neurava, Nextsense, Eysz, and Byteflies who are developing advanced technologies to improve seizure detection and monitoring, elevating the standard of care.

Precision Medicine
We are shifting our development approach, to include more targeted, precision based interventions – which is critical to support those who have historically been difficult to treat. With acquisitions such as Engage Theraputics, and investments in collaborations with GliaPharm and Praxis Precision Medicines we are complementing our in house efforts to help identify new therapeutic targets in epilepsy and explore the discovery of small molecule therapeutics as potential treatments of KCNT1 related epilepsies) We do this with an eye toward developing potentially disease modifying treatments that could one day lead to a cure for epilepsy.

Using RWE to Understand
Seizure Clusters
We’re collaborating with Le Bonheur Children s Hospital, the Wisconsin Health Information Organization (WHIO), and Yale University to examine the impact of seizure clusters on patient and caregiver quality of life, leveraging the power of education and real world evidence (RWE) to address this research gap, expand awareness, and enact positive change in the health outcomes of individuals with seizure clusters.

Health Equity
We purposefully partner with patient led and focused organizations to increase connections across the healthcare industry, address health disparities in underrepresented and underserved communities such as the Hispanic and black communities, and help ease burdens people living with epilepsy and their caregivers are facing.

Epilepsy Advocate™
Created in 2006 EpilepsyAdvocate is a community of people living with epilepsy, their family members, and their caregivers. When it comes to epilepsy, knowledge is power. Whether you’ve had epilepsy for years or you are newly diagnosed, the more you know, the more you can do to try to control epilepsy and live life on your terms.

Exploring Epilepsy Today
Let’s Explore Epilepsy Together.
We believe that the health gaps among social, economic, racial, age, ethnic, and geographical groups that affect millions of Americans living with epilepsy are simply not acceptable. Our goal is to raise the standard of care for the communities we serve, which starts with informing you.

UCB Family Epilepsy
Scholarship Program
Our annual UCB Family Epilepsy Scholarship program offers educational scholarships to people living with epilepsy, family members, and caregivers. Since 2004, UCB has awarded over $3 million in scholarships to more than 600 recipients who have applied their awards to undergraduate and graduate studies.